The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jerash Holdings (US) Inc
NASDAQ:JRSH
|
US |
|
Indo Kordsa Tbk PT
IDX:BRAM
|
ID |
|
F
|
FACC AG
SWB:1FC
|
AT |
|
MariMed Inc
OTC:MRMD
|
US |
|
Ley Choon Group Holdings Ltd
SGX:Q0X
|
SG |
|
A
|
Atlanta Poland SA
WSE:ATP
|
PL |
|
Addex Therapeutics Ltd
LSE:0QNV
|
CH |
|
J
|
Jinko Power Technology Co Ltd
SSE:601778
|
CN |
|
Bragg Gaming Group Inc
F:SL4
|
CA |
|
N
|
Nichia Steel Works Ltd
TSE:5658
|
JP |
|
Tega Industries Ltd
NSE:TEGA
|
IN |
|
Grupo Televisa SAB
NYSE:TV
|
MX |
|
B
|
British Land Company PLC
F:BLD
|
UK |
|
Yankuang Energy Group Co Ltd
F:YZC
|
CN |
|
National Bank of Canada
TSX:NA
|
CA |
|
Toyota Motor Corp
NYSE:TM
|
JP |
|
Unisia Holdings Co
TSE:3547
|
JP |
|
E
|
Endurance Gold Corp
F:3EG
|
CA |
|
Emperor Energy Ltd
ASX:EMP
|
AU |
|
C
|
CNH Industrial NV
DUS:37C
|
UK |
|
C
|
Champion Iron Ltd
OTC:CIAFF
|
AU |
|
H
|
H & R Block Inc
XMUN:HRB
|
US |
|
C
|
Chung Lien Co Ltd
TPEX:5604
|
TW |
|
Toyo Seikan Group Holdings Ltd
TSE:5901
|
JP |
Jerash Holdings (US) Inc (JRSH)’s 12-month stock price forecast through October 2027 has a consensus target of $6.63, implying 9% upside. The forecast is based on price targets from 4 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
JRSH is 6.63 USD with a low forecast of 6.06 USD and a high forecast of 7.35 USD.
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 4 years is 11%.
Over the last 10 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 4 years is 13%.
Over the last 10 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 4 years is 28%.
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been -6%. The projected CAGR for the next 3 years is 40%.
Over the last 10 years, the compound annual growth rate for Net Income has been -9%. The projected CAGR for the next 4 years is 34%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more